Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

FOXO

FOXO Technologies Inc

Apr 26 • 04:00PM ET

0.2825

Dollar change +0.0014
Percentage change 0.50	%

Healthcare • Health Information Services • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.23	Insider Own	68.16%	Shs Outstand	8.95M	Perf Week	5.81%
Market Cap	2.53M	Forward P/E	-	EPS next Y	-	Insider Trans	-7.58%	Shs Float	2.85M	Perf Month	-19.29%
Income	-43.38M	PEG	-	EPS next Q	-	Inst Own	3.77%	Short Float	7.37%	Perf Quarter	0.86%
Sales	2.68M	P/S	0.94	EPS this Y	-	Inst Trans	-81.10%	Short Ratio	0.19	Perf Half Y	-72.06%
Book/sh	-1.81	P/B	-	EPS next Y	-	ROA	-146.48%	Short Interest	0.21M	Perf Year	-95.28%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-1754.50%	52W Range	0.25 - 5.28	Perf YTD	-11.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-94.64%	Beta	1.84
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	13.00%	ATR (14)	0.03
Dividend Ex-Date	-	Current Ratio	0.19	EPS Y/Y TTM	76.69%	Oper. Margin	-1286.23%	RSI (14)	43.62	Volatility	10.24% 10.28%
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-618.36%	Profit Margin	-1619.30%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	88.80%	Payout	-	Rel Volume	0.19	Prev Close	0.28
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	99.92%	Earnings	-	Avg Volume	1.12M	Price	0.28
SMA20	-9.40%	SMA50	-12.16%	SMA200	-62.27%	Trades		Volume	215,865	Change	0.50%

Apr-23-24 05:00PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (GlobeNewswire)
Feb-14-24 09:32AM	FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global (GlobeNewswire) -8.50%
Jan-25-24 05:00PM	FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors (Business Wire)
Jan-22-24 08:30AM	FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions (Business Wire) -14.49%
Dec-19-23 08:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire)
09:01AM	Loading…
Dec-01-23 09:01AM	FOXO Technologies On Track to Commence Commercial Rollout of VITHAR AI Health Coach in Early 2024 (Business Wire) +22.82%
Nov-29-23 04:30PM	FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q (Business Wire) -5.49%
Nov-10-23 08:30AM	FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR AI Health Coach (Business Wire)
Nov-08-23 09:00AM	FOXO Technologies to Unveil VITHAR AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time (Business Wire) -21.89%
Nov-07-23 09:23AM	FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split (Business Wire) -17.53%
Oct-30-23 08:30AM	FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Companys Epigenetic Data with the Power of AI (Business Wire) -24.80%
Oct-27-23 05:15PM	FOXO Technologies Inc. Announces Reverse Stock Split (Business Wire) -6.99%
Oct-23-23 08:00AM	FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy (Business Wire)
Oct-13-23 08:00AM	FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers (Business Wire) +8.47%
Oct-06-23 08:30AM	FOXO Technologies Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions (Business Wire) +17.20%
08:30AM	Loading…
Sep-06-23 08:30AM	FOXO Technologies Announces Agreement With Atrio Insurance (Business Wire) +14.48%
Aug-31-23 08:30AM	FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan (Business Wire) +7.97%
Aug-18-23 04:15PM	FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American (Business Wire)
Aug-17-23 08:30AM	FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity (Business Wire)
Aug-10-23 04:05PM	FOXO Technologies Announces Second Quarter 2023 Financial Results (Business Wire)
Aug-08-23 08:30AM	FOXO Technologies Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT (Business Wire) -9.77%
Aug-07-23 08:30AM	Longevity Biotech Companies GERO and FOXO Technologies to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories (Business Wire) -7.98%
Jul-19-23 08:00AM	FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis (Business Wire) +19.07%
Jun-16-23 05:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire) -5.02%
May-30-23 05:09PM	FOXO Technologies Announces Results of Annual Stockholders Meeting (Business Wire) +14.60%
May-17-23 04:30PM	NYSE American Has Commenced Delisting Proceedings in the FOXO WS warrants of FOXO Technologies Inc. (Business Wire)
May-11-23 04:15PM	FOXO Technologies Announces First Quarter 2023 Financial Results (Business Wire)
Apr-18-23 08:00AM	FOXO Technologies Announces Resignation of Taylor Fay, Chief Operating Officer (Business Wire) -8.08%
08:00AM	FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product (Business Wire)
Mar-30-23 04:05PM	FOXO Technologies Announces Full Year 2022 Financial Results and Recent Business Highlights (Business Wire)
07:00PM	Loading…
Mar-22-23 07:00PM	FOXO Technologies Inc. Sets Fourth Quarter and Full Year 2022 Business Update Call for Thursday, March 30, 2023 at 3:15 p.m. CT (Business Wire)
Dec-08-22 04:15PM	FOXO LIFE to Begin Distribution Relationship with AmSuisse to Sell Life Insurance Designed to Keep You Alive (Business Wire)
Nov-23-22 06:30PM	FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 (Business Wire) -13.33%
Nov-15-22 12:57PM	FOXO Technologies Announces Management Changes and Delays Filing of Form 10-Q (Business Wire) -12.85%
01:24AM	FOXO Technologies Announces Departure of Chief Product Officer, Erin Sharoni (Business Wire)
Nov-14-22 04:31PM	FOXO Technologies Postpones Third Quarter 2022 Earnings Report and Conference Call (Business Wire) +6.64%
08:00AM	FOXO Technologies Announces Agreement With Haven Life (Business Wire)
Nov-07-22 04:01PM	FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT (Business Wire)
Oct-12-22 08:00AM	FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent (Business Wire) +59.30%

FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company was founded in 2020 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WHITE MARK BRIAN	Interim CEO	Feb 06 '24	Sale	0.42	250,000	105,000	0	Feb 07 03:07 PM
WARD MARTIN CHRISTOPHER	Interim CFO	Feb 06 '24	Sale	0.42	250,000	105,000	0	Feb 07 03:07 PM
Dowling Vincent J. Jr	10% Owner	Jul 14 '23	Sale	0.16	3,000	491	4,647,405	Jul 18 03:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FOXO

FOXO Technologies Inc

Upgrade your FINVIZ experience